{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04757116",
            "orgStudyIdInfo": {
                "id": "MT-08"
            },
            "organization": {
                "fullName": "Olympus Corporation of the Americas",
                "class": "INDUSTRY"
            },
            "briefTitle": "Post-Market Study to Assess iTind Safety in Comparison to UroLift",
            "officialTitle": "A Post-Market, Prospective, Randomized, Controlled, Multicenter International Study to Assess the Safety of the Temporarily Implanted Nitinol Device (iTind) Compared to the UroLift\u00ae System in Subjects With Symptomatic Benign Prostatic Hyperplasia (BPH)",
            "acronym": "MT-08",
            "therapeuticArea": [
                "Other"
            ],
            "study": "post-market-study-to-assess-itind-safety-in-comparison-to-urolift"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-09-26",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2030-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-02-07",
            "studyFirstSubmitQcDate": "2021-02-14",
            "studyFirstPostDateStruct": {
                "date": "2021-02-17",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-03",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-06",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Olympus Corporation of the Americas",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The study objective is to evaluate the safety of the iTind device comparied to UroLift.",
            "detailedDescription": "UroLift is a treatment for relieving lower urinary tract symptoms (LUTS) secondary to benign Prostatic Hyperplasia (BPH) as a minimally invasive procedure. This procedure has proven to have high efficacy with regards to improving objective and subjective parameters. The iTind is a minimally invasive temporary device designed to relieve LUTS secondary to BPH. This study is designed to compare the minimally invasive iTind device to UroLift."
        },
        "conditionsModule": {
            "conditions": [
                "Benign Prostatic Hyperplasia (BPH)"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 206,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "iTind arm",
                    "type": "EXPERIMENTAL",
                    "description": "The iTind is a minimally invasive temporary implant",
                    "interventionNames": [
                        "Device: iTind"
                    ]
                },
                {
                    "label": "UroLift",
                    "type": "EXPERIMENTAL",
                    "description": "The UroLift is a minimally invasive permanent implant",
                    "interventionNames": [
                        "Procedure: UroLift"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "iTind",
                    "description": "The iTind is implemented for 5-7 days",
                    "armGroupLabels": [
                        "iTind arm"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "UroLift",
                    "description": "UroLift is a minimally invasive procedure where permanent implants are placed in the prostate.",
                    "armGroupLabels": [
                        "UroLift"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of all intraoperative and post-operative complications",
                    "description": "Incidence of all intraoperative and post-operative complications (i.e., related to procedure and/or device) at 3 months",
                    "timeFrame": "3 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Difference in change from baseline between iTind and UroLift groups in International Prostate Symptom Score (IPSS)",
                    "description": "Difference in change of International Prostate Symptom Score (IPSS) from baseline between iTind and UroLift groups at 1, 3, 6, 12, 24, 36, 48, and 60 months.",
                    "timeFrame": "1, 3, 6, 12, 24, 36, 48, and 60 months"
                },
                {
                    "measure": "Difference in change from baseline between iTind and UroLift groups in Sexual Health Inventory for Men (SHIM)",
                    "description": "Difference in change of Sexual Health Inventory for Men (SHIM) scores from baseline between iTind and UroLift at 1, 3, 6, 12, 24, 36, 48, and 60 months.",
                    "timeFrame": "1, 3, 6, 12, 24, 36, 48, and 60 months"
                },
                {
                    "measure": "Difference in change from baseline between iTind and UroLift groups in Male Sexual Health Questionnaire for assessing ejaculatory dysfunction (MSHQ-EjD)",
                    "description": "Difference in change of in Male Sexual Health Questionnaire for assessing ejaculatory dysfunction (MSHQ-EjD) scores from baseline between iTind and UroLift at 1, 3, 6, 12, 24, 36, 48, and 60 months.",
                    "timeFrame": "1, 3, 6, 12, 24, 36, 48, and 60 months"
                },
                {
                    "measure": "Difference in change from baseline between iTind and UroLift groups in Short-Form Six-Dimension (SF-6D) v2",
                    "description": "Difference in change of Short-Form Six-Dimension (SF-6D) v2 scores from baseline between iTind and UroLift at 1, 3, 6, 12, 24, 36, 48, and 60 months.",
                    "timeFrame": "1, 3, 6, 12, 24, 36, 48, and 60 months"
                },
                {
                    "measure": "Difference in rate of re-intervention between iTind and UroLift groups",
                    "description": "Difference in rate of re-intervention between iTind and UroLift groups at 1, 3, 6, 12, 18, 24, 36, 48, and 60 months",
                    "timeFrame": "1, 3, 6, 12, 18, 24, 36, 48, and 60 months"
                },
                {
                    "measure": "Difference in reporting between iTind and UroLift groups in overall incidence of adverse events.",
                    "description": "Difference in reporting between iTind and UroLift groups at 1, 3, 6, 12, 18, 24, 36, 48, and 60 months in overall incidence of adverse events.",
                    "timeFrame": "1, 3, 6, 12, 18, 24, 36, 48, and 60 months"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Difference between iTind and UroLift groups for concomitant medication usage",
                    "description": "Difference between iTind and UroLift groups for the following parameters:\n\n\u2022 Concomitant medication usage",
                    "timeFrame": "Time frame not specified for exploratory endpoint"
                },
                {
                    "measure": "Difference between iTind and UroLift groups for Anesthesia type",
                    "description": "Difference between iTind and UroLift groups for the following parameters:\n\n\u2022 Anesthesia type",
                    "timeFrame": "Intraoperative"
                },
                {
                    "measure": "Difference between iTind and UroLift groups for Procedure time",
                    "description": "Difference between iTind and UroLift groups for the following parameters:\n\n\u2022 Procedure time",
                    "timeFrame": "Intraoperative"
                },
                {
                    "measure": "Difference between iTind and UroLift groups for Hospital length of stay",
                    "description": "Difference between iTind and UroLift groups for the following parameters:\n\n\u2022 Hospital length of stay",
                    "timeFrame": "Post-procedure"
                },
                {
                    "measure": "Difference between iTind and UroLift groups for Post-operative foley catheterization",
                    "description": "Difference between iTind and UroLift groups for the following parameters:\n\n\u2022 Post-operative foley catheterization",
                    "timeFrame": "Post-procedure"
                },
                {
                    "measure": "Difference between iTind and UroLift groups for Number of UroLift impants (UroLift arm only)",
                    "description": "Difference between iTind and UroLift groups for the following parameters:\n\n\u2022 Number of UroLift impants (UroLift arm only)",
                    "timeFrame": "Intraoperative"
                },
                {
                    "measure": "Difference between iTind and UroLift groups for iTind retrieval time (iTind arm only)",
                    "description": "Difference between iTind and UroLift groups for the following parameters:\n\n\u2022 iTind retrieval time (iTind arm only)",
                    "timeFrame": "Intraoperative"
                },
                {
                    "measure": "Difference between iTind and UroLift groups for iTind post-retrieval foley catheterization (iTind arm only)",
                    "description": "Difference between iTind and UroLift groups for the following parameters:\n\n\u2022 iTind post-retrieval foley catheterization (iTind arm only)",
                    "timeFrame": "Post-procedure"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Diagnosis of lower urinary tract symptoms presumed to be secondary to benign prostatic enlargement causing bladder outlet obstruction for which treatment is recommended\n2. Willing and able to provide informed consent\n3. Males \u2265 50 years of age or older\n4. PSA \\< 4 ng/dl, ng/ml or if the PSA is 4 - 10 ng/dl, ng/ml, prostate cancer must be ruled out to the satisfaction of the Principal Investigator (PI) by local standard of care methods within prior 6 months\n5. Prostate volume up to 75 cc (inclusive) documented by cross-sectional imaging (TRUS, MRI, etc.). Results from standard of care imaging may be accepted up to 6 months prior to Screening if the subject was not on 5-alpha reductase inhibitors (5ARIs) at that time\n6. International Prostate Symptom Score (IPSS) \u2265 13\n7. Maximum urinary flow rate (Qmax) of \u2264 15 mL/sec and \u2265 5 mL/sec (voided volume must be \u2265 125 mL)\n8. Willing and able to complete all study visits including questionnaires at baseline and at follow-up visits\n\nExclusion Criteria:\n\n1. History of prostate cancer or suspected, should be ruled out to the satisfaction of the PI by local standard of care methods within prior 6 months\n2. Confirmed or suspected bladder cancer within the last 2 years\n3. History of acute bacterial prostatitis within the last 2 years\n4. Median lobe obstruction of the prostate as confirmed by cross-sectional imaging\n5. PSA value \\> 10 ng/dl, ng/ml\n6. Contraindicated for iTind or UroLift as determined by the PI\n7. Neurogenic bladder and/or sphincter abnormalities due to Parkinson's disease, multiple sclerosis, cerebral vascular accident, diabetes or other neurological disorders that affect bladder function\n8. Clinically significant bladder diverticulum\n9. Diagnosed with urethral stricture, meatal stenosis, bladder neck contracture, rectal disease, artificial urinary sphincter, incompetent sphincter, urinary incontinence due to incompetent sphincter\n10. Prior rectal surgery (other than hemorrhoidectomy) or history of rectal disease if the therapy may potentially cause injury to sites or previous rectal surgery (e.g., if a transrectal probe is used), pelvic radiotherapy or radical pelvic surgery, urinary diversion surgery, prostate surgery, balloon dilation, urethral stent implantation, laser prostatectomy, or any other invasive treatment to the prostate, or penile prosthesis that may prevent insertion of the iTind or UroLift device\n11. An active urinary tract infection\n12. Hematuria or cystolithiasis within the last 3 months\n13. Prostate volume \\> 75 cc\n14. Post-void residual volume (PVR) \\> 250 mL\n15. Actively using catheterization or unable to void naturally\n16. Unable to complete the required washout period for alpha blockers\n17. Taking anti-platelet or anticoagulants (except low dose aspirin - 81 mg - 100 mg) within the last 7 days prior to randomization\n18. Known or suspected allergy to nickel, titanium or polyester/polypropylene",
            "healthyVolunteers": false,
            "sex": "MALE",
            "minimumAge": "50 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Selen ZuelbaharOlgun, PhD",
                    "role": "CONTACT",
                    "phone": "1-650-586-2171",
                    "email": "Selen.ZuelbaharOlgun@olympus.com"
                },
                {
                    "name": "Meaghan Dunn, MS",
                    "role": "CONTACT",
                    "phone": "508479-2769",
                    "email": "mdunn@hallorancg.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Bilal Chughtai, MD",
                    "affiliation": "Plainview Hospital",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Neil Barber, MD",
                    "affiliation": "Frimley Park Hospital",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Arizona Urology Specialists",
                    "status": "RECRUITING",
                    "city": "Tucson",
                    "state": "Arizona",
                    "zip": "85704",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Andrea Navarette",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Kalpesh Patel, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.22174,
                        "lon": -110.92648
                    }
                },
                {
                    "facility": "Golden State Urology",
                    "status": "RECRUITING",
                    "city": "Sacramento",
                    "state": "California",
                    "zip": "95823",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sejah Sethi",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Prithipal Sethi, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.58157,
                        "lon": -121.4944
                    }
                },
                {
                    "facility": "Northwestern University",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60611",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rahul Prabhu",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Channa Amarasekera, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "NorthShore University Health System Research Institute",
                    "status": "RECRUITING",
                    "city": "Evanston",
                    "state": "Illinois",
                    "zip": "60201",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Pooja Talaty",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Brian Helfand, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.04114,
                        "lon": -87.69006
                    }
                },
                {
                    "facility": "Southeast Louisiana Veterans Health Care System",
                    "status": "RECRUITING",
                    "city": "New Orleans",
                    "state": "Louisiana",
                    "zip": "70119",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kristen Lingle",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Louis Krane, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.95465,
                        "lon": -90.07507
                    }
                },
                {
                    "facility": "The Urology Place",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78240",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Victoria Sarwan",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Naveen Kella, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "Frimley Park Hospital",
                    "status": "RECRUITING",
                    "city": "London",
                    "zip": "GU16 7UJ",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Alexander Edwards",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Neil Barber, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                },
                {
                    "facility": "Norfolk & Norwich University Hospital",
                    "status": "RECRUITING",
                    "city": "Norwich",
                    "zip": "NR4 7UY",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Mark Rochester, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Mark Rochester, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.62783,
                        "lon": 1.29834
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Company website",
                    "url": "https://www.itind.com/"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30",
            "removedCountries": [
                "Canada"
            ]
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011470",
                    "term": "Prostatic Hyperplasia"
                },
                {
                    "id": "D000006965",
                    "term": "Hyperplasia"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000011469",
                    "term": "Prostatic Diseases"
                },
                {
                    "id": "D000005832",
                    "term": "Genital Diseases, Male"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M14334",
                    "name": "Prostatic Hyperplasia",
                    "asFound": "Prostatic Hyperplasia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10016",
                    "name": "Hyperplasia",
                    "asFound": "Hyperplasia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14333",
                    "name": "Prostatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8944",
                    "name": "Genital Diseases, Male",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        }
    },
    "hasResults": false
}